Update on the “Choosing Wisely” initiative in infectious diseases in Germany by Draenert, Rika & Jung, Norma
Vol.:(0123456789) 
Infection (2020) 48:317–321 
https://doi.org/10.1007/s15010-020-01400-z
REVIEW
Update on the “Choosing Wisely” initiative in infectious diseases 
in Germany
Rika Draenert1  · Norma Jung2 · the Choosing Wisely (Klug entscheiden) DGI Working Group
Received: 3 February 2020 / Accepted: 6 February 2020 / Published online: 10 March 2020 
© The Author(s) 2020
Abstract
Purpose The Choosing  Wisely® initiative is an international campaign addressing over- and underuse of diagnostic and 
therapeutic measures in infectious diseases among others. Since 2016, the German Society for Infectious Diseases (DGI) 
has constantly designed new items in this regard. Here we report the most recent recommendations.
Methods The recommendations of the DGI are part of the “Klug entscheiden” initiative of the German Society of Internal 
Medicine (DGIM). Topics for the new items were suggested by members of the DGI, checked for scientific evidence and 
consented within the DGI and the DGIM before publication.
Results The new recommendations are: (1) individuals with immune-suppression, advanced liver cirrhosis or renal insuf-
ficiency should receive a dual pneumococcal vaccination. (2) In case of positive blood cultures with Candida spp. thorough 
diagnostics and treatment should be initiated. (3) In case of suspected meningitis, adult patients should receive dexametha-
sone and antibiotics immediately after venipuncture for blood cultures and before potential imaging. (4) In case of suspected 
meningitis a CT scan before lumbar puncture should not be ordered—except for symptoms indicating high CSF pressure or 
focal brain pathology or in cases of severe immune-suppression. (5) In patients with suspected severe infections, a minimum 
of two pairs of blood cultures should be drawn using separate venipunctures prior to antibiotic therapy—regardless of body 
temperature. There is no need of a minimum time interval in between the blood draws.
Conclusion Applying these new Choosing  Wisely® recommendations will increase patient safety and the value of health care.
Keywords Choosing Wisely · Infectious diseases · Vaccination · Meningitis · Blood cultures
Introduction
The Choosing  Wisely® campaign was first initiated in the 
USA in 2012. Soon other countries followed, including Ger-
many. Since 2016, 125 recommendations have been pub-
lished in the section of infectious diseases as well as other 
specialties of Internal Medicine in Germany [1]. However, a 
further development seems pertinent as there are still many 
areas untouched so far.
Vaccination acceptance is a main concern of the German 
Society of Infectious Diseases (DGI), especially in times 
of waning vaccination rates due to increasing scepticism 
to vaccination globally. Therefore, vaccines were included 
in the recommendations of the DGI from the beginning. 
Besides a rational application of antibiotics and other anti-
infectives, fungal diseases are of utmost importance as their 
incidence is increasing, and they mostly occur in severely ill 
and vulnerable patients leading to a high mortality rate. Dif-
ficulties to deal with comprise the diagnosis as well as treat-
ment conditions including the dosage and serum levels of 
antifungals as well as drug–drug interactions. Another area 
of concern to the DGIM is the emergency department. Here 
the time constraint due to high patient numbers and seriously 
ill individuals has to be taken into account. Last but not least 
diagnostics are a most relevant issue in infectious diseases, 
providing the opportunity of characterizing the causative 
agent in detail which is crucial for the optimal antimicro-
bial treatment. On the other hand, overuse of diagnostics 
can delay the urgently needed application of antibiotics. All 
this is reflected in the new recommendations—positive and 
negative—presented here.
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Methods
The Choosing  Wisely® recommendations were created as 
described previously [2]. Shortly, committee members of 
the DGI suggested important issues suitable for new Choos-
ing  Wisely® items which were checked for scientific evi-
dence and overlap to older recommendations. Two general 
and three emergency room recommendations were finally 
chosen. After the out-writing of the recommendations, they 
were discussed and consented by the Choosing  Wisely® 
commission of the DGI and the DGIM. The recommenda-
tions concerning bacterial meningitis were jointly agreed 
upon by the German Society of Neurology (DGN).
Results
General recommendations
Individuals with immune-suppression, advanced liver cir-
rhosis or renal insufficiency should receive a dual pneumo-
coccal vaccination.
Patients with immune-suppression are exposed to a sig-
nificantly higher risk of severe pneumococcal infections, 
depending on the kind of immune suppression, with the 
highest risk after splenectomy. Additional conditions which 
are associated with immune-suppression such as chronic 
liver cirrhosis and renal insufficiency or certain anatomi-
cal risks (e.g. cerebrospinal fluid leaks or cochlea implants) 
are predisposing factors for pneumococcal infections. Since 
2016, the “STIKO” (the German Commission on Vaccina-
tion) recommends a dual vaccination with the 13-valent con-
jugate vaccine (PCV13) followed by the 23-valent polysac-
charide vaccine (PPSV23) 6–12 months later in these patient 
groups. If the polysaccharide vaccine has been given previ-
ously, the conjugate vaccine should not be used before the 
course of 1 year, to achieve a better immune response. There 
are specific vaccination schedules for patients after stem cell 
transplantation. Compared to the polysaccharide inoculum, 
the conjugate vaccine induces memory cells. Especially for 
HIV infected individuals, a protective effect of the conjugate 
inoculum was shown whereas this could not be demonstrated 
for the polysaccharide vaccine. The 13-valent conjugate vac-
cine, however, comprises only about 30% of pneumococcal 
infections in adults, in contrast the 23-valent polysaccharide 
inoculum about 60–70%. Therefore, the sequential vaccina-
tion with both inocula conveys the best protection against 
pneumococcal infections at the moment [3–8].
In case of positive blood cultures with Candida spp. thor-
ough diagnostics and treatment should be initiated.
Candida spp. are a frequent cause of bloodstream infec-
tions und are associated with a mortality of 30–40%. Even a 
single positive blood culture with Candida spp. is relevant. 
For the medical treatment, echinocandins are primarily used 
due to their superior efficacy and their favourable profile 
regarding adverse events. Fluconazole is not a safe first-line 
regimen. Treatment duration is at least 14 days starting with 
the first negative blood culture which should be performed 
on close follow-up after the first positive culture. After docu-
mented clearance of Candida spp. from the blood stream, 
the therapy can be switched to fluconazole or voriconazole if 
the causative organism was tested susceptible and the clini-
cal status is stable. In certain cases, oral administration of 
antifungals is also possible. One of the key factors in the 
management of Candida spp. bloodstream infections is the 
identification of the correct focus. Intravascular catheters 
should be removed immediately. If the Candida spp. blood-
stream infection persists for more than 4 days echocardiog-
raphy should be performed to rule out Candida endocarditis 
[9–11].
Recommendations for the emergency department
In case of suspected meningitis, adult patients should receive 
dexamethasone and antibiotics immediately after venipunc-
ture for blood cultures and before potential imaging.
Bacterial meningitis is a severe infection with high mor-
bidity and mortality. Every delay in treatment is associated 
with a worse prognosis. Antibiotics—directly after dexa-
methasone—should be given as soon as possible after pres-
entation to the emergency department.
Typical symptoms are fever, headache, nuchal rigidity, 
altered mental status and massive reduction of well-being; 
the absence of single symptoms including nuchal rigidity, 
however, does not exclude bacterial meningitis. In suspected 
meningitis, blood draw and lumbar puncture should be per-
formed immediately. In case of a delay of lumbar puncture 
(e.g. indication for cranial CT before the procedure), antibi-
otics should be given before lumbar puncture is performed 
[12–16].
In case of suspected meningitis a CT scan before lum-
bar puncture should not be ordered—except for symptoms 
indicating high cerebrospinal fluid (CSF) pressure or focal 
brain pathology or in cases of severe immuno-suppression.
Within the diagnostics for bacterial meningitis, a lumbar 
puncture is of paramount importance in order to confirm the 
diagnosis, to identify the causative agent and its resistance 
profile. It is mandatory for an optimal antibiotic therapy. A 
cranial CT scan before lumbar puncture can delay the appli-
cation of antibiotics and dexamethasone and is performed 
too often in daily clinical practice which is not according to 
current guidelines. Indications for a cranial CT scan preced-
ing lumbar puncture are: (1) focal neurological symptoms, 
(2) first-time epileptic seizures, (3) massive altered mental 
status (GCS < 10) or (4) severe immunosuppression.
319Update on the “Choosing Wisely” initiative in infectious diseases in Germany 
1 3
Patients without one of the aforementioned criteria do not 
need a cranial CT scan because the detection of abnormali-
ties leading to contraindication against lumbar puncture is 
highly unlikely.
Severe immunosuppression is defined—among others—
as: severe innate immunodeficiency, CD4 cell count < 200/
µl, status post allogeneic stem cell or organ transplantation, 
intensive immunosuppression with two or more drugs, cor-
ticosteroid intake of > 0.5 mg/kg/day (prednisolone equiva-
lent) within the last 4 weeks or longer [16–24].
In patients with suspected severe infections, a minimum 
of two pairs of blood cultures should be drawn using sepa-
rate venipunctures prior to antibiotic therapy—regardless of 
body temperature. There is no necessity of a minimum time 
interval in between these blood draws.
Severe infections (e.g. sepsis, septic shock, meningitis, 
pneumonia, endocarditis) requiring hospital admission are 
common diseases in emergency departments. For optimal 
treatment of these severe diseases, knowledge of the causa-
tive agent is essential. Bacteremia is frequently associated 
with a severe course of infection, e.g. concomitant bacte-
remia is found in about 40% of the cases in pneumococcal 
pneumonia. Therefore, blood cultures are an important diag-
nostic tool. Contrary to earlier assumptions, there is no cor-
relation between rising fever and a high bacterial load in the 
blood. The sensitivity of blood culture diagnostics increases 
from 73 (one pair of blood cultures) to 90% in case that two 
pairs of blood cultures are drawn. In suspected endocardi-
tis, three pairs of blood cultures should always be drawn. 
The time interval between the blood culture venipunctures 
is not important. However, blood cultures should be drawn 
at different venipuncture sites in order to be able to recog-
nize contamination easily. The time point of venipuncture 
is rather secondary and it should not delay the urgent start 
of antimicrobial therapy [25–29].
Discussion
Here, we report the advancement of the Choosing  Wisely® 
recommendations in the field of infectious diseases in Ger-
many. Preventive measures such as vaccinations and the 
diagnostic and therapeutic management of Candida spp. 
bloodstream infections and meningitis present the focus of 
this round’s items.
The Choosing  Wisely® campaign was initiated in 2012 
in the USA. Since then several countries have started 
their own campaigns. This initiative is not terminated but 
new recommendations are being developed continuously 
reflecting the medical need. Accordingly, the collection 
has been developed further during the past years in Ger-
many, now also including special aspects in medicine, 
e.g. emergency medicine and vaccinations. This was done 
particularly due to the common assessment of the commis-
sion that many important questions had not been touched 
yet.
A point of debate within the Choosing  Wisely® cam-
paign is a targeted distribution to suitable addressees. How 
can this be made known to a substantial proportion of doc-
tors? The DGIM has approached this with publications in 
widely read journals in Germany, lectures and sessions 
on conferences and—just recently—e-learning modules 
using learning by case solving (https ://www.klug-entsc 
heide n.com/). However, additional multipliers are desir-
able in order to ascertain wide-spread publicity not only 
among physicians in the hospital and in the private prac-
tices but also directly among patients—the latter being an 
important principle of the Choosing  Wisely® campaign, 
namely encouraging the critical dialogue between patients 
and their physicians.
The augmentation of the Choosing  Wisely® collection 
leads to the question of acceptance. At the moment, the 
implementation of our recommendations is not assessed 
and therefore unclear in Germany. It would be desirable, 
however, to evaluate the proportion of physicians using 
the recommendations in their daily activities and the pro-
portion of doctor-patient conversations regarding applica-
tion of the recommendations in real-life medicine. Other 
countries, however, have started to address this question 
[30–34]. Physicians in France found it feasible to adopt 
the Choosing  Wisely® recommendations concerning mul-
tiple sclerosis [31]. In USA, primary care providers were 
ambiguous: Choosing  Wisely® items regarding not testing 
in asymptomatic patients were widely accepted and fol-
lowed. On the other hand, items concerning testing and 
treatment in symptomatic patients revealed difficulties in 
acceptance especially for patients [30]. A large Canadian 
study revealed that patients are willing to abstain from 
low-value practices when educated accordingly [33]. Mal-
practice concerns, patient requests for services and lack of 
time for shared decision making were the most frequently 
cited obstacles to reducing low-value practices in the USA 
[30].
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